Kekule Life Sciences Limited, a active public limited company, was established on 20 August 2013 in Hyderabad, Telangana, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U74900TG2013PLC089588. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹10.00 Cr and a paid-up capital of ₹8.00 Cr.
It upholds a compliant status. Employing 40 professional, Its leadership includes Sridhar Vootla (Managing Director), Srilakshmi Kudaravalli (Director), Apparao Vootla (Director). Past directors included Sailaja Kolli, Adarsh Kumar Kacham, Kondru Rao Jagadeeswara. It holds ₹8.32 Cr open charges and ₹21.35 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot 406 A, H. No. 622 Road No. 18, Near Andhra Bank, Jubilee H, Ills, Hyderabad, Telangana, 500033.
U74900TG2013PLC089588
089588
20 August 2013
₹10.00 Cr
₹8.00 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Kekule Life Sciences Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sridhar Vootla | Managing Director | 20 Aug 2013 | Current |
| Srilakshmi Kudaravalli | Director | 11 Oct 2019 | Current |
| Apparao Vootla | Director | 20 Aug 2013 | Current |
| Kudaravalli Raja Rao | Director | 20 Aug 2013 | Current |
| Kudaravalli Sridhar | Director | 20 Aug 2013 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 05 Feb 2018 | Past |
| Pramod Abcsdd | Director | 03 Mar 2025 | Past |
| Pramod Abcsdd | Director | 11 Oct 2019 | Past |
| Pramod Abcsdd | Whole-Time Director | 16 Feb 2022 | Past |
| Pramod Abcsdd | Additional Director | 31 Dec 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Kekule Life Sciences Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 36.64% decrease. The company also saw a substantial fall in profitability, with a 28.93% decrease in profit. The company's net worth observed a substantial decline by a decrease of 13.82%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Kekule Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹83,200,000.00
₹213,450,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Sep 2024 | Others | ₹8.32 Cr | Open |
| 29 Mar 2023 | Others | ₹5.70 M | Satisfied |
| 04 Jul 2022 | Others | ₹1.43 Cr | Satisfied |
| 10 Jul 2020 | Others | ₹1.27 Cr | Satisfied |
| 13 May 2020 | Others | ₹5.75 M | Satisfied |
Explore comprehensive loan charge details -
Kekule Life Sciences has a workforce of 40 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Kekule Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kekule Life Sciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge registered on 29 Mar 2023 via Charge ID 100719378 with Others was fully satisfied on 18 Jan 2025. was completed.
The activity A charge registered on 10 Jul 2020 via Charge ID 100354800 with Others was fully satisfied on 18 Jan 2025. was completed.
A charge registered on 17 Sep 2014 via Charge ID 10530871 with Bank Of Baroda was fully satisfied on 18 Jan 2025. was recorded as a recent event.
Progress on A charge with Others of Rs. 8.32 Cr registered on 30 Sep 2024 with Charge ID 101005187 was modified on 08 Jan 2025. was documented.
Progress on A charge with Others amounted to Rs. 8.32 Cr with Charge ID 101005187 was registered on 30 Sep 2024. was documented.
Progress on Kekule Life Sciences Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The CIN of Kekule Life Sciences Limited is U74900TG2013PLC089588.
Kekule Life Sciences Limited is headquartered at Plot 406 A, H. No. 622 Road No. 18, Near Andhra Bank, Jubilee H, Ills, Hyderabad, Telangana, 500033.
Kekule Life Sciences Limited was incorporated on 20 August 2013.
The current directors of Kekule Life Sciences Limited are
The primary industry of Kekule Life Sciences Limited is Manufacturing.
Kekule Life Sciences Limited is unlisted.
The authorized capital of Kekule Life Sciences Limited is ₹10.00 Cr, and the paid-up capital is ₹8.00 Cr.
The compliance status of Kekule Life Sciences Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX